IRIS
CHIARITO, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.612
AS - Asia 2.746
EU - Europa 925
SA - Sud America 559
Continente sconosciuto - Info sul continente non disponibili 121
AF - Africa 81
OC - Oceania 5
Totale 8.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.495
SG - Singapore 1.548
CN - Cina 563
BR - Brasile 464
VN - Vietnam 273
IT - Italia 262
FI - Finlandia 154
DE - Germania 117
IE - Irlanda 98
IN - India 79
HK - Hong Kong 63
CA - Canada 52
FR - Francia 51
GB - Regno Unito 50
SE - Svezia 44
AR - Argentina 34
MX - Messico 33
NG - Nigeria 32
BD - Bangladesh 31
NL - Olanda 31
TR - Turchia 27
ID - Indonesia 24
IQ - Iraq 24
PL - Polonia 15
RU - Federazione Russa 15
JP - Giappone 13
PY - Paraguay 12
UA - Ucraina 12
ES - Italia 11
MA - Marocco 11
CL - Cile 10
CO - Colombia 10
SA - Arabia Saudita 10
VE - Venezuela 9
AZ - Azerbaigian 8
KE - Kenya 8
MY - Malesia 8
ZA - Sudafrica 8
EC - Ecuador 7
PE - Perù 7
PK - Pakistan 7
TH - Thailandia 7
BE - Belgio 6
JM - Giamaica 6
RO - Romania 6
TW - Taiwan 6
AT - Austria 5
BO - Bolivia 5
BY - Bielorussia 5
DZ - Algeria 5
EG - Egitto 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
LT - Lituania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KG - Kirghizistan 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
UZ - Uzbekistan 4
CR - Costa Rica 3
CU - Cuba 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
CH - Svizzera 2
CY - Cipro 2
HR - Croazia 2
LB - Libano 2
LV - Lettonia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 7.917
Salva come PNG Salva come JPEG
Città #
Singapore 670
Ashburn 435
San Jose 419
The Dalles 248
Shanghai 240
Chandler 193
Council Bluffs 173
Dallas 169
New York 158
Helsinki 153
Beijing 138
Boardman 118
Wilmington 109
Los Angeles 105
Milan 98
Dublin 97
Ho Chi Minh City 86
Santa Clara 70
Hanoi 57
Hong Kong 54
San Mateo 50
São Paulo 46
Pune 38
Benin City 32
Chicago 32
Buffalo 29
Munich 28
Rome 27
Lawrence 22
Princeton 22
Falkenstein 21
Ann Arbor 20
Amsterdam 19
Seattle 19
Brooklyn 18
Leawood 16
Orem 16
Phoenix 15
Charlotte 14
Warsaw 14
Woodbridge 14
Brasília 13
Da Nang 13
Fairfield 13
Haiphong 13
Montreal 13
Curitiba 12
Toronto 12
Frankfurt am Main 11
Naples 11
Paris 11
Turin 11
Hillsboro 10
Rio de Janeiro 10
Stockholm 10
Cologno Monzese 9
Assago 8
Chennai 8
Denver 8
Mexico City 8
Baghdad 7
Boston 7
Goiânia 7
Houston 7
Johannesburg 7
Kocaeli 7
Kuala Lumpur 7
London 7
Manchester 7
Tokyo 7
Asunción 6
Baku 6
Biên Hòa 6
Brussels 6
Can Tho 6
Hải Dương 6
Lima 6
Moscow 6
Norwalk 6
Thái Nguyên 6
Abbiategrasso 5
Ankara 5
Athens 5
Brescia 5
Campinas 5
Columbus 5
Istanbul 5
Juiz de Fora 5
Kingston 5
Nairobi 5
Newark 5
Porto Alegre 5
Redmond 5
Reston 5
San Francisco 5
Santo André 5
Taipei 5
Atlanta 4
Belo Horizonte 4
Bologna 4
Totale 4.733
Salva come PNG Salva come JPEG
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 148
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 140
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 134
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 121
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 112
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 110
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 106
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 104
Prognostic role of mitral regurgitation in patients with advanced heart failure 93
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 90
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 90
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort 89
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 87
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 87
The synergy stent in high-bleeding risk patients: why design matters 86
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 85
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 82
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 82
Characterization of Myocardial Injury in Patients With COVID-19 81
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 80
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 79
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 77
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 77
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 76
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 76
A Complicated Case of Resistant Hypertension 75
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 74
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 73
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 72
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 72
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 71
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 71
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 71
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 70
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 69
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 68
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 66
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 66
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 66
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 65
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 64
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 63
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 63
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 63
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 62
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 61
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 60
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 59
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 59
Weather conditions and incidence of acute coronary syndromes: a large-scale analysis based on national healthcare system administrative data 58
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 58
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 58
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 58
Early Experience with the Symetis bioprosthesis in real world patients: The Milan Registry 58
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 58
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 58
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 58
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 56
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 56
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 56
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 55
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 55
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 55
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 54
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 54
The crucial role of the heart valve team in the management of a complex case of multivalvular disease and heart failure 53
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 53
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 53
Prognostic value of tricuspid regurgitation 53
Drug-eluting stents in diabetic patients: Are we still treading water? 52
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 52
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 52
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 52
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 51
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 51
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 51
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 50
Types of myocardial injury and mid-term outcomes in patients with COVID-19 49
Low-Dose Colchicine after Myocardial Infarction 49
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 49
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 49
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 49
Prognostic value of hypochloremia on mortality in patients with heart failure: a systematic review and meta-analysis 49
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 49
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 48
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 48
Panta rhei, also drug eluting stent technology 47
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 47
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 47
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis 46
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 46
Left main coronary artery disease: when and how to perform PCI? 45
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 45
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events 44
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 44
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 44
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 44
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 43
Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough? 43
One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients 43
Totale 6.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022132 0 2 5 28 3 1 4 23 11 8 34 13
2022/2023760 54 18 32 96 75 48 16 45 151 106 89 30
2023/2024963 93 87 175 80 37 115 61 62 20 51 84 98
2024/20251.422 32 5 29 24 23 169 86 109 231 353 191 170
2025/20263.961 527 296 214 335 157 211 1.084 197 174 269 170 327
2026/2027594 291 303 0 0 0 0 0 0 0 0 0 0
Totale 8.049